|
Prolong Pharmaceuticals creates proprietary, high-value biopharmaceuticals utilizing a delivery system known as PEGylation. PEGylation is the only FDA-approved protein delivery technology that transforms proteins into superior drug products, by attaching a polyethylene glycol ("PEG") polymer to a therapeutic protein. This process, developed by the company's founder, results in an improved product with significantly enhance potency, fewer side effects, and a reduced dosing frequency.
What's New
CEO of Prolong gives 2009 commencement address at Rutgers University.
May 21, 2009
| 
